FARMINGDALE, N.Y., Nov. 3 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of cancer and worldwide for other acute health conditions, today announced that Michael A. McManus, Jr., President and Chief Executive Officer, will present at the Rodman & Renshaw 10th Annual Healthcare Conference to be held on November 10-12 at the New York Palace Hotel in New York City.
Mr. McManus is scheduled to present on Wednesday, November 12, 2008 at 3:15 p.m. ET. The presentation will be accessible via live webcast at http://www.wsw.com/webcast/rrshq14/mson and will also be archived on the Misonix website for a period of 90 days. For more information on the conference please visit the conference website http://www.rodm.com/conferences?id=19.
Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at http://www.misonix.com.
|SOURCE Misonix, Inc.|
Copyright©2008 PR Newswire.
All rights reserved